当前位置:首页 - 行情中心 - 太龙药业(600222) - 财务分析 - 现金流量表

太龙药业

(600222)

  

流通市值:43.79亿  总市值:43.79亿
流通股本:5.74亿   总股本:5.74亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金288,022,291.481,656,679,498.411,197,876,027.92823,784,786.09
  收到的税费返还-0--
  收到其他与经营活动有关的现金2,178,580.049,618,055.518,407,148.595,417,805.34
  经营活动现金流入小计290,200,871.521,666,297,553.921,206,283,176.51829,202,591.43
  购买商品、接受劳务支付的现金332,668,591.721,107,253,003.49927,180,790.99696,218,549.63
  支付给职工以及为职工支付的现金79,723,259.28303,863,376.69229,968,331158,727,411.35
  支付的各项税费29,115,948.6870,648,803.4452,785,570.5432,850,227.11
  支付其他与经营活动有关的现金46,345,709.42137,374,363.0885,337,525.1653,088,037.44
  经营活动现金流出小计487,853,509.11,619,139,546.71,295,272,217.69940,884,225.53
  经营活动产生的现金流量净额-197,652,637.5847,158,007.22-88,989,041.18-111,681,634.1
二、投资活动产生的现金流量:
  收回投资收到的现金100,000,000130,076,002.79124,219,785.66122,019,785.66
  取得投资收益收到的现金39,259.7338,799,799.0522,993,898.0422,992,730.64
  处置固定资产、无形资产和其他长期资产收回的现金净额-68,62160,42660,426
  处置子公司及其他营业单位收到的现金净额-88,813.011,582,224-
  收到的其他与投资活动有关的现金-000
  投资活动现金流入小计100,039,259.73169,033,235.85148,856,333.7145,072,942.3
  购建固定资产、无形资产和其他长期资产支付的现金3,126,238.9521,122,400.0812,061,211.876,611,350.79
  投资支付的现金-147,750,00047,750,00047,750,000
  投资活动现金流出小计3,126,238.95168,872,400.0859,811,211.8754,361,350.79
  投资活动产生的现金流量净额96,913,020.78160,835.7789,045,121.8390,711,591.51
三、筹资活动产生的现金流量:
  取得借款收到的现金530,400,0001,038,887,940.49830,018,450.51702,635,766.27
  收到其他与筹资活动有关的现金469,500,000883,832,141.55760,975,349.61314,900,000
  筹资活动现金流入小计999,900,0001,922,720,082.041,590,993,800.121,017,535,766.27
  偿还债务支付的现金298,805,891.771,240,412,873.44880,682,009.99553,540,971.74
  分配股利、利润或偿付利息支付的现金24,066,432.1450,763,605.8439,608,231.0628,338,146.36
  支付其他与筹资活动有关的现金623,114,351.34646,910,152.66495,939,310.12340,096,080.17
  筹资活动现金流出小计945,986,675.251,938,086,631.941,416,229,551.17921,975,198.27
  筹资活动产生的现金流量净额53,913,324.75-15,366,549.9174,764,248.9595,560,568
五、现金及现金等价物净增加额-46,826,292.0531,952,293.09174,820,329.674,590,525.41
  加:期初现金及现金等价物余额175,845,198.94143,892,905.85143,892,905.85143,892,905.85
  期末现金及现金等价物余额129,018,906.89175,845,198.94318,713,235.45218,483,431.26
补充资料:
  净利润-65,867,565.55-22,601,677.95
  资产减值准备-5,615,222.38--9,807,663.33
  固定资产和投资性房地产折旧-46,100,998.43-23,959,380.24
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-46,100,998.43-23,959,380.24
  无形资产摊销-5,894,001.28-2,905,223.24
  长期待摊费用摊销-8,760,944.66-4,469,147.1
  处置固定资产、无形资产和其他长期资产的损失-23,974-0
  固定资产报废损失-134,784.03-73,320.16
  公允价值变动损失--1,399,054.4--1,451,657.5
  财务费用-58,981,205.42-27,156,765.34
  投资损失-154,766.82-596,645.68
  递延所得税-7,916,119.87--146,132.52
  其中:递延所得税资产减少-4,895,650.98--2,388,444.72
    递延所得税负债增加-3,020,468.89-2,242,312.2
  存货的减少-9,944,921.38--108,237,768.17
  经营性应收项目的减少--218,708,643.37--2,248,894.6
  经营性应付项目的增加-23,219,412.38--81,857,859.17
  现金的期末余额-175,845,198.94-218,483,431.26
  减:现金的期初余额-143,892,905.85-143,892,905.85
  现金及现金等价物的净增加额-31,952,293.09-74,590,525.41
公告日期2026-04-302026-04-152025-10-302025-08-27
审计意见(境内)标准无保留意见
TOP↑